PACSIN2 and diabetic kidney disease: Relying on a rat model for obesity, diabetes and severe DKD, along with human nephrectomy samples and serum samples from individuals with type 2 diabetes (T2D), we show that the phosphorylation of PACSIN2 at S313 associates with increased circulating free fatty acids (FFA) and kidney dysfunction.